Drug
Ripretinib
Ripretinib: highest development phase Phase 2, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ripretinib NCT04633122 | Phase 2 | Gastrointestinal Stromal Tumor(GIST) |
Latest
No recent events.
Follow Ripretinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.